Tag: Obesity
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D
Risk reduced for 10 of 13 obesity-associated cancers with GLP-1 RA use versus insulin in individuals with type 2 diabetes
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
Significantly lower risk of major adverse cardiovascular events, all-cause mortality seen in metabolic surgery group
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD
Greatest total estimated mean change in weight loss with combination of exercise and liraglutide
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA
Two randomized controlled trials show reduction in AHI; significant improvements seen in all secondary end points
Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder
Findings show risk cut in half based on electronic health record data
Intermittent Fasting Aids Early Diabetes Outcomes More Than Drugs
Benefits include improved glycemic outcomes and weight loss at 16 weeks in the short term compared with metformin or empagliflozin
Timing of Exercise Significant for Obesity, Metabolic Impairment
Beneficial effect on glucose hemostasis seen for accumulation of more MVPA in the evening for sedentary adults
Meal Replacement + Financial Incentives Beneficial for Teens With Obesity
For teens with severe obesity, meal replacement therapy plus financial incentives result in greater reduction in BMI, fat mass
Overweight in Teens, Young Adults Tied to Cerebrovascular Disease in Women
Risk for ischemic cerebrovascular disease increased at ages 14 and 31 years for women with overweight, independent of earlier or later BMI
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
Authors found that BMI of ≥27 shows excellent diagnostic performance
